Harnessing AI for Market Visibility and Strategic Growth in the MedTech Sector

Client
A leading international MedTech company focused on large institutional markets.
Primary Goal
Enhance market visibility and strategic decision-making to capture competitive market share and improve profitability.
Vamstar Capability
- AI-powered Data Orchestration
- Net Price and Market Analytics
- Market Share and Growth Insights

Introduction

The client, a prominent player in the MedTech industry, was struggling with inadequate visibility into key markets, particularly those driven by distributors.

Relying on inconsistent data from external reports and distributors, the leadership sought a more reliable and comprehensive way to understand market dynamics and drive growth.

Key outcomes

At Vamstar, we’re committed to transforming the life science market access and supply chain landscape with cutting-edge technology and unparalleled support.

4.5% improvement in overall margins.
9.2% increase in revenues.
Strategic introduction of new products and differentiation plans

Transformation Journey

Before Vamstar
During our collaboration
After

The company faced significant challenges in gaining a clear understanding of market trends due to unreliable data sources.

Efforts to manually navigate and analyse tenders were cumbersome and inefficient, leading to missed opportunities and strategic missteps. Additionally, procedure data was also inconsistent and not timely updated. This resulted in poor and unreliable forecasts.

Harness AI to drive growth

Take a step towards improving your commercial operations, Register today

Resources

Case Studies

Leveraging AI-led Insights for Strategic Biosimilar Licensing Negotiations

In the fiercely competitive biosimilars market, two prominent pharmaceutical companies were navigating the complexities of multi-asset licensing arrangements and needed to reevaluate investment strategies.

Revolutionising Tender Bidding Strategies with AI: A Case Study of Vamstar’s Pricing Co-Pilot for a Top-10 Generics Company

A leading pharmaceutical company with a robust international presence and growing operations in Europe found itself grappling with increased competition in the generics market, particularly in tenders following Loss of Exclusivity (LoE), where market prices plummeted by up to 95%.

Revenue Risk and Opportunity Assessment for Changing ESG Requirements from Key Accounts/ Buyers in Europe.

A global manufacturer of medical devices and consumables needed to evaluate how emerging ESG (Environmental, Social, and Governance) requirements would impact product marketability across the EU4, UK, and Nordics. Seeking to better understand market risks and opportunities, the client approached Vamstar for insights into differentiation strategies to expand market share.

Let’s talk

Book a 30 minutes meeting with us

Welcome to our scheduling page! Please choose an available date below to get started.

30 minutes meeting

We’ll email you the meeting link